 |
市場調查報告書
商品編碼
1697903
全球臨床營運與開發市場：市場規模、佔有率、趨勢、產業分析（按階段、服務類型、適應症、最終用途和地區）、未來預測（2025-2034）Clinical Operations and Development Market Size, Share, Trends, Industry Analysis Report: By Phase, Service Type, Indication, and Region - Market Forecast, 2025-2034 |
||||||
價格
根據Polaris Market Research的最新研究，到2034年臨床營運和開發市場預計將達到1,762.9億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。
臨床營運和開發市場包括臨床試驗的規劃、實施和管理，以評估新藥和新療法的安全性和有效性。該市場在製藥和生物技術行業中發揮著至關重要的作用，加速了藥物開發過程，同時確保滿足監管標準。慢性病的增加、臨床試驗的日益複雜以及個人化醫療的進步正在推動臨床操作和開發市場的需求。
製藥業研發活動的激增促使對臨床營運和開發服務的需求穩定成長。癌症、神經系統疾病和罕見疾病的增加推動了臨床試驗數量的增加。例如，由於癌症治療的複雜性，包括免疫療法和標靶療法，腫瘤學領域的臨床試驗需要廣泛的安全性評估。此類服務的需求受到 FDA 和 EMA 等機構施加的嚴格監管要求的推動，這些機構要求嚴格的臨床試驗方案以確保病患安全和資料完整性。
隨著分散臨床試驗 (DCT) 和人工智慧研究方法的引入，臨床營運和開發市場正在經歷重大轉變。這些進步正在改善患者的招募和保留，特別是在中樞神經系統 (CNS) 疾病等具有課題性的治療領域。歐洲擁有多樣化的患者群體和強大的醫療保健基礎設施，仍然是臨床操作和發展的關鍵地區。該地區適度的人口增長和政府對研發的支持為臨床營運和開發市場的擴張提供了有利的機會。臨床操作的不斷發展將在塑造藥物開發的未來方面發揮關鍵作用。
臨床營運與開發市場：分析概述
從階段來看，大規模臨床試驗、監管要求、人工智慧驅動優化的出現以及RWE的整合正在推動臨床試驗效率和市場發展，從而促使III期臨床試驗在2024年佔據臨床營運和開發市場佔有率的主導地位。
根據服務類型，實驗室服務和生物分析測試部門預計在預測期內將實現最高的複合年增長率，這得益於先進分析技術、生物標記分析、個人化醫療和藥物開發法規遵從性的採用。
由於不斷增加的醫藥投資、先進的測試技術、監管支援、人工智慧整合以及 Elligo Health Research 的人工智慧驅動數據連接平台等創新，北美在臨床營運和開發市場收入佔有率方面處於領先地位。
全球主要公司包括ClinChoice、Thermo Fisher Scientific Inc.（PPD Inc.）、IQVIA、Charles River Laboratories、Syneos Health、Eli Lilly and Company、Pfizer Inc.、Novo Nordisk A/S、Parexel International（MA）Corporation、Caidya。
目錄
第1章 引言
第2章 執行摘要
第3章分析方法
第4章全球臨床營運與開發市場洞察
- 臨床營運與開發：產業概況
- 價值鏈分析
- 臨床營運和開發市場動態
- 推動因素和機遇
- 全球慢性病盛行率不斷上升
- 擴大新興國家的醫療基礎設施
- 阻礙因素和課題
- 合規性
- 波特五力分析
- 供應商的議價能力（低到中等）
- 新進入者的威脅（第二部）
- 買方議價能力（中）
- 替代產品的威脅（中到高）
- 公司之間的競爭（高）
- PESTLE 分析
第5章臨床營運與開發市場分階段評估
- 介紹
- 第一階段
- 第二階段
- 第三階段
- 第四階段
第6章按服務類型評估臨床營運和開發市場
- 介紹
- 實驗室服務/生物分析測試：BA/BE
- 資料管理和生物統計服務
- 現場管理和監控服務
- 醫學寫作與出版服務
- 病患招募和保留服務
- 其他
第7章 依適應症評估臨床營運與開發市場
- 介紹
- 腫瘤學
- 中樞神經系統 (CNS) 疾病
- 心血管疾病（CVD）
- 代謝/內分泌
- 呼吸的
- 感染
- 其他
第8章臨床營運和開發市場按地區評估
- 介紹
- 北美臨床營運與開發市場
- 按國家
- 相別
- 按服務類型
- 按指示
- 美國臨床營運與開發市場
- 加拿大臨床營運和開發市場
- 歐洲臨床營運與開發市場
- 按國家
- 相別
- 按服務類型
- 按指示
- 英國臨床營運與開發市場
- 法國臨床營運與開發市場
- 德國臨床營運與開發市場
- 義大利臨床營運與開發市場
- 西班牙臨床營運與開發市場
- 荷蘭臨床營運與開發市場
- 俄羅斯臨床營運與開發市場
- 其他歐洲臨床營運與發展市場
- 亞太臨床營運與開發市場
- 按國家
- 相別
- 按服務類型
- 按指示
- 中國臨床營運及開發市場
- 日本的臨床營運與開發市場
- 韓國臨床營運與開發市場
- 印度臨床營運與開發市場
- 澳洲臨床營運與開發市場
- 亞太地區其他臨床營運和開發市場
- 拉丁美洲臨床營運與開發市場
- 按國家
- 相別
- 按服務類型
- 按指示
- 巴西臨床營運與開發市場
- 墨西哥的臨床營運和開發市場
- 阿根廷的臨床營運和開發市場
- 其他拉丁美洲臨床營運與開發市場
- 中東和非洲臨床營運和發展市場
- 按國家
- 相別
- 按服務類型
- 按指示
- 阿聯酋臨床營運和開發市場
- 以色列臨床營運與開發市場
- 沙烏地阿拉伯臨床營運和開發市場
- 南非臨床營運與發展市場
- 其他中東和非洲臨床營運和發展市場
第9章競爭格局
- 主要市場參與者：分類
- 戰略框架
- 供應商情況
- 策略分類
- 啟動/擴張/投資
- 夥伴關係/合作/收購
第10章 公司簡介
- ClinChoice
- Thermo Fisher Scientific Inc.（PPD Inc.）
- IQVIA
- Charles River Laboratories
- Syneos Health
- Eli Lilly and Company
- Pfizer Inc.
- Novo Nordisk A/S
- Parexel International（MA）Corporation
- Caidya
Product Code: PM5388
The clinical operations and development market size is expected to reach USD 176.29 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Operations and Development Market Size, Share, Trends, Industry Analysis Report: By Phase (Phase I, Phase II, Phase III, and Phase IV), Service Type, Indication, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The clinical operations and development market encompasses the planning, execution, and management of clinical trials to evaluate the safety and efficacy of new drugs and medical treatments. This market plays a vital role in the pharmaceutical and biotechnology industries, ensuring that regulatory standards are met while accelerating the drug development process. The increasing prevalence of chronic diseases, growing complexity of clinical trials, and advancements in personalized medicine drive the clinical operations and development market demand.
The demand for clinical operations and development services is steadily rising due to the surge in research and development activities within the pharmaceutical sector. The increasing prevalence of cancer, neurological disorders, and rare diseases has led to a higher volume of clinical trials. For instance, oncology clinical trials require extensive safety evaluations due to the complexity of cancer therapies, including immunotherapies and targeted treatments. The demand for these services is reinforced by stringent regulatory requirements imposed by agencies such as the FDA and EMA, which mandate rigorous trial protocols to ensure patient safety and data integrity.
The clinical operations and development market has witnessed significant transformation with the adoption of decentralized clinical trials (DCTs) and AI-driven research methodologies. These advancements have improved patient recruitment and retention, particularly in challenging therapeutic areas such as central nervous system (CNS) disorders. Europe remains a key region for clinical operations and developments, offering a diverse patient population and strong healthcare infrastructure. The gradual population growth in the region, coupled with government support for research initiatives, presents lucrative opportunities for clinical operations and development market expansion. The continued evolution of clinical operations plays a crucial role in shaping the future of drug development.
Clinical Operations and Development Market Report Highlights
By phase, the phase III segment dominated the clinical operations and development market share in 2024, driven by large-scale trials, regulatory requirements, emergence of AI-driven optimization, and real-world evidence integration, enhancing trial efficiency and market growth.
By service type, the laboratory services and bioanalytical testing segment is projected to register the highest CAGR during the forecast period, driven by the adoption of advanced analytical techniques, biomarker analysis, and personalized medicine, as well as regulatory compliance in drug development.
North America leads the clinical operations and development market revenue share, driven by rising pharmaceutical investments, advanced trial technologies, regulatory support, AI integration, and innovations such as Elligo Health Research's AI-driven Data Connect platform.
A few global key market players are ClinChoice, Thermo Fisher Scientific Inc. (PPD Inc.), IQVIA, Charles River Laboratories, Syneos Health, Eli Lilly and Company, Pfizer Inc., Novo Nordisk A/S, Parexel International (MA) Corporation, and Caidya.
Polaris Market Research has segmented the clinical operations and development market report on the basis of phase, service type, indication, and region:
By Phase Outlook (Revenue, USD Billion, 2020-2034)
- Phase I
- Phase II
- Phase III
- Phase IV
By Service Type Outlook (Revenue, USD Billion, 2020-2034)
- Laboratory Services & Bioanalytical Testing
- Data Management & Biostatistics Services
- Site Management & Monitoring Services
- Medical Writing & Publishing Services
- Patient Recruitment & Retention Services
- Others
By Indication Outlook (Revenue, USD Billion, 2020-2034)
- Oncology
- Central Nervous System (CNS) Disorders
- Cardiovascular Disease (CVD)
- Metabolic/Endocrine Diseases
- Respiratory Diseases
- Infectious Diseases
- Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
Chapter 1. Introduction
- 1.1 Report Description
- 1.1.1 Objective of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
- 1.2 Stakeholders
Chapter 2. Research Methodology
- 2.1 Research Methodology
- 2.2 Research Scope and Assumptions
- 2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
- 2.4 Information Analysis
- 2.4.1 Data Analysis Models
- 2.5 Market Formulation and Data Visualization
- 2.6 Data Validation and Publishing (Secondary Sources)
Chapter 3. Executive Summary
Chapter 4. Market Insights
- 4.1 Clinical Operations and Development - Industry snapshot
- 4.2 Clinical Operations and Development Market - Value Chain Analysis
- 4.2.1 Clinical Operations and Development Market Dynamics
- 4.2.2 Drivers and Opportunities
- 4.2.2.1 Growing Prevalence of Chronic Diseases Globally
- 4.2.2.2 Expanding Healthcare Infrastructure in Emerging Economies
- 4.2.3 Restraints and Challenges
- 4.2.3.1 Regulatory Compliance
- 4.3 Clinical Operations and Development Market - Porter's Five Forces
- 4.3.1 Threat of Substitutes: Low to Moderate
- 4.3.2 Threat of New Entrants: Moderate
- 4.3.3 Bargaining power of buyers: Moderate
- 4.3.4 Bargaining power of suppliers: Moderate to High
- 4.3.5 Competitive Rivalry: High
- 4.4 Clinical Operations and Development Market - PESTLE Analysis
Chapter 5. Clinical Operations and Development Market Assessment, By Phase
- 5.1 Introduction
- 5.2 Phase I
- 5.3 Phase II
- 5.4 Phase III
- 5.5 Phase IV
Chapter 6. Clinical Operations and Development Market Assessment, By Service Type
- 6.1 Introduction
- 6.2 Laboratory Services & Bioanalytical Testing - BA/BE
- 6.3 Data Management & Biostatistics Services
- 6.4 Site Management & Monitoring Services
- 6.5 Medical Writing & Publishing Services
- 6.6 Patient Recruitment & Retention Services
- 6.7 Others
Chapter 7. Clinical Operations and Development Market Assessment, By Indication
- 7.1 Introduction
- 7.2 Oncology
- 7.3 Central Nervous System (CNS) Disorders
- 7.4 Cardiovascular Diseases (CVD)
- 7.5 Metabolic/Endocrine
- 7.6 Respiratory
- 7.7 Infectious Diseases
- 7.8 Others
Chapter 8. Clinical Operations and Development Market Assessment, By Region
- 8.1 Introduction
- 8.2 North America Clinical Operations and Development Market
- 8.2.1 North America Clinical Operations and Development Market, By Country
- 8.2.2 North America Clinical Operations and Development Market, By Phase
- 8.2.3 North America Clinical Operations and Development Market, By Service Type
- 8.2.4 North America Clinical Operations and Development Market, By Indication
- 8.2.5 US Clinical Operations and Development Market
- 8.2.5.1 US Clinical Operations and Development Market, By Phase
- 8.2.5.2 US Clinical Operations and Development Market, By Service Type
- 8.2.5.3 US Clinical Operations and Development Market, By Indication
- 8.2.6 Canada Clinical Operations and Development Market
- 8.2.6.1 Canada Clinical Operations and Development Market, By Phase
- 8.2.6.2 Canada Clinical Operations and Development Market, By Service Type
- 8.2.6.3 Canada Clinical Operations and Development Market, By Indication
- 8.3 Europe Clinical Operations and Development Market
- 8.3.1 Europe Clinical Operations and Development Market, By Country
- 8.3.2 Europe Clinical Operations and Development Market, By Phase
- 8.3.3 Europe Clinical Operations and Development Market, By Service Type
- 8.3.4 Europe Clinical Operations and Development Market, By Indication
- 8.3.5 UK Clinical Operations and Development Market
- 8.3.5.1 UK Clinical Operations and Development Market, By Phase
- 8.3.5.2 UK Clinical Operations and Development Market, By Service Type
- 8.3.5.3 UK Clinical Operations and Development Market, By Indication
- 8.3.6 France Clinical Operations and Development Market
- 8.3.6.1 France Clinical Operations and Development Market, By Phase
- 8.3.6.2 France Clinical Operations and Development Market, By Service Type
- 8.3.6.3 France Clinical Operations and Development Market, By Indication
- 8.3.7 Germany Clinical Operations and Development Market
- 8.3.7.1 Germany Clinical Operations and Development Market, By Phase
- 8.3.7.2 Germany Clinical Operations and Development Market, By Service Type
- 8.3.7.3 Germany Clinical Operations and Development Market, By Indication
- 8.3.8 Italy Clinical Operations and Development Market
- 8.3.8.1 Italy Clinical Operations and Development Market, By Phase
- 8.3.8.2 Italy Clinical Operations and Development Market, By Service Type
- 8.3.8.3 Italy Clinical Operations and Development Market, By Indication
- 8.3.9 Spain Clinical Operations and Development Market
- 8.3.9.1 Spain Clinical Operations and Development Market, By Phase
- 8.3.9.2 Spain Clinical Operations and Development Market, By Service Type
- 8.3.9.3 Spain Clinical Operations and Development Market, By Indication
- 8.3.10 Netherlands Clinical Operations and Development Market
- 8.3.10.1 Netherlands Clinical Operations and Development Market, By Phase
- 8.3.10.2 Netherlands Clinical Operations and Development Market, By Service Type
- 8.3.10.3 Netherlands Clinical Operations and Development Market, By Indication
- 8.3.11 Russia Clinical Operations and Development Market
- 8.3.11.1 Russia Clinical Operations and Development Market, By Phase
- 8.3.11.2 Russia Clinical Operations and Development Market, By Service Type
- 8.3.11.3 Russia Clinical Operations and Development Market, By Indication
- 8.3.12 Rest of Europe Clinical Operations and Development Market
- 8.3.12.1 Rest of Europe Clinical Operations and Development Market, By Phase
- 8.3.12.2 Rest of Europe Clinical Operations and Development Market, By Service Type
- 8.3.12.3 Rest of Europe Clinical Operations and Development Market, By Indication
- 8.4 Asia Pacific Clinical Operations and Development Market
- 8.4.1 Asia Pacific Clinical Operations and Development Market, By Country
- 8.4.2 Asia Pacific Clinical Operations and Development Market, By Phase
- 8.4.3 Asia Pacific Clinical Operations and Development Market, By Service Type
- 8.4.4 Asia Pacific Clinical Operations and Development Market, By Indication
- 8.4.5 China Clinical Operations and Development Market
- 8.4.5.1 China Clinical Operations and Development Market, By Phase
- 8.4.5.2 China Clinical Operations and Development Market, By Service Type
- 8.4.5.3 China Clinical Operations and Development Market, By Indication
- 8.4.6 Japan Clinical Operations and Development Market
- 8.4.6.1 Japan Clinical Operations and Development Market, By Phase
- 8.4.6.2 Japan Clinical Operations and Development Market, By Service Type
- 8.4.6.3 Japan Clinical Operations and Development Market, By Indication
- 8.4.7 South Korea Clinical Operations and Development Market
- 8.4.7.1 South Korea Clinical Operations and Development Market, By Phase
- 8.4.7.2 South Korea Clinical Operations and Development Market, By Service Type
- 8.4.7.3 South Korea Clinical Operations and Development Market, By Indication
- 8.4.8 India Clinical Operations and Development Market
- 8.4.8.1 India Clinical Operations and Development Market, By Phase
- 8.4.8.2 India Clinical Operations and Development Market, By Service Type
- 8.4.8.3 India Clinical Operations and Development Market, By Indication
- 8.4.9 Australia Clinical Operations and Development Market
- 8.4.9.1 Australia Clinical Operations and Development Market, By Phase
- 8.4.9.2 Australia Clinical Operations and Development Market, By Service Type
- 8.4.9.3 Australia Clinical Operations and Development Market, By Indication
- 8.4.10 Rest of Asia Pacific Clinical Operations and Development Market
- 8.4.10.1 Rest of Asia Pacific Clinical Operations and Development Market, By Phase
- 8.4.10.2 Rest of Asia Pacific Clinical Operations and Development Market, By Service Type
- 8.4.10.3 Rest of Asia Pacific Clinical Operations and Development Market, By Indication
- 8.5 Latin America Clinical Operations and Development Market
- 8.5.1 Latin America Clinical Operations and Development Market, By Country
- 8.5.2 Latin America Clinical Operations and Development Market, By Phase
- 8.5.3 Latin America Clinical Operations and Development Market, By Service Type
- 8.5.4 Latin America Clinical Operations and Development Market, By Indication
- 8.5.5 Brazil Clinical Operations and Development Market
- 8.5.5.1 Brazil Clinical Operations and Development Market, By Phase
- 8.5.5.2 Brazil Clinical Operations and Development Market, By Service Type
- 8.5.5.3 Brazil Clinical Operations and Development Market, By Indication
- 8.5.6 Mexico Clinical Operations and Development Market
- 8.5.6.1 Mexico Clinical Operations and Development Market, By Phase
- 8.5.6.2 Mexico Clinical Operations and Development Market, By Service Type
- 8.5.6.3 Mexico Clinical Operations and Development Market, By Indication
- 8.5.7 Argentina Clinical Operations and Development Market
- 8.5.7.1 Argentina Clinical Operations and Development Market, By Phase
- 8.5.7.2 Argentina Clinical Operations and Development Market, By Service Type
- 8.5.7.3 Argentina Clinical Operations and Development Market, By Indication
- 8.5.8 Rest of Latin America Clinical Operations and Development Market
- 8.5.8.1 Rest of Latin America Clinical Operations and Development Market, By Phase
- 8.5.8.2 Rest of Latin America Clinical Operations and Development Market, By Service Type
- 8.5.8.3 Rest of Latin America Clinical Operations and Development Market, By Indication
- 8.6 Middle East and Africa Clinical Operations and Development Market
- 8.6.1 Middle East and Africa Clinical Operations and Development Market, By Country
- 8.6.2 Middle East and Africa Clinical Operations and Development Market, By Phase
- 8.6.3 Middle East and Africa Clinical Operations and Development Market, By Service Type
- 8.6.4 Middle East and Africa Clinical Operations and Development Market, By Indication
- 8.6.5 UAE Clinical Operations and Development Market
- 8.6.5.1 UAE Clinical Operations and Development Market, By Phase
- 8.6.5.2 UAE Clinical Operations and Development Market, By Service Type
- 8.6.5.3 UAE Clinical Operations and Development Market, By Indication
- 8.6.6 Israel Clinical Operations and Development Market
- 8.6.6.1 Israel Clinical Operations and Development Market, By Phase
- 8.6.6.2 Israel Clinical Operations and Development Market, By Service Type
- 8.6.6.3 Israel Clinical Operations and Development Market, By Indication
- 8.6.7 Saudi Arabia Clinical Operations and Development Market
- 8.6.7.1 Saudi Arabia Clinical Operations and Development Market, By Phase
- 8.6.7.2 Saudi Arabia Clinical Operations and Development Market, By Service Type
- 8.6.7.3 Saudi Arabia Clinical Operations and Development Market, By Indication
- 8.6.8 South Africa Clinical Operations and Development Market
- 8.6.8.1 South Africa Clinical Operations and Development Market, By Phase
- 8.6.8.2 South Africa Clinical Operations and Development Market, By Service Type
- 8.6.8.3 South Africa Clinical Operations and Development Market, By Indication
- 8.6.9 Rest of Middle East & Africa Clinical Operations and Development Market
- 8.6.9.1 Rest of Middle East & Africa Clinical Operations and Development Market, By Phase
- 8.6.9.2 Rest of Middle East & Africa Clinical Operations and Development Market, By Service Type
- 8.6.9.3 Rest of Middle East & Africa Clinical Operations and Development Market, By Indication
Chapter 9. Competitive Landscape
- 9.1 Key Market Players: Categorization
- 9.2 Strategy Framework
- 9.3 Vendor Landscape
- 9.4 Strategies Categorization
- 9.4.1 Launch/ Expansion/ Investment
- 9.4.2 Partnership/ Collaboration/ Acquisition
Chapter 10. Company Profiles
- 10.1 ClinChoice
- 10.1.1 Business Overview
- 10.1.2 Service Benchmarking
- 10.1.3 Recent Developments
- 10.2 Thermo Fisher Scientific Inc. (PPD Inc.)
- 10.2.1 Business Overview
- 10.2.2 Financial Snapshot
- 10.2.2.1 Revenue by Segment
- 10.2.2.2 Revenue by Region
- 10.2.3 Service Benchmarking
- 10.2.4 Recent Developments
- 10.3 IQVIA
- 10.3.1 Business Overview
- 10.3.2 Financial Snapshot
- 10.3.2.1 Revenue by Market Segment
- 10.3.2.2 Revenue by Region
- 10.3.3 Service Benchmarking
- 10.3.4 Recent Developments
- 10.4 Charles River Laboratories
- 10.4.1 Business Overview
- 10.4.2 Financial Snapshot
- 10.4.2.1 Revenue by Market Segment
- 10.4.2.2 Revenue by Region
- 10.4.3 Service Benchmarking
- 10.4.4 Recent Developments
- 10.5 Syneos Health
- 10.5.1 Business Overview
- 10.5.2 Service Benchmarking
- 10.5.3 Recent Developments
- 10.6 Eli Lilly and Company
- 10.6.1 Business Overview
- 10.6.2 Financial Snapshot
- 10.6.2.1 Revenue by Market Segment
- 10.6.2.2 Revenue by Region
- 10.6.3 Service Benchmarking
- 10.6.4 Recent Developments
- 10.7 Pfizer Inc.
- 10.7.1 Business Overview
- 10.7.2 Financial Snapshot
- 10.7.2.1 Revenue by Market Segment
- 10.7.3 Service Benchmarking
- 10.7.4 Recent Developments
- 10.8 Novo Nordisk A/S
- 10.8.1 Business Overview
- 10.8.2 Financial Snapshot
- 10.8.2.1 Revenue by Market Segment
- 10.8.2.2 Revenue by Region
- 10.8.3 Service Benchmarking
- 10.8.4 Recent Developments
- 10.9 Parexel International (MA) Corporation
- 10.9.1 Business Overview
- 10.9.2 Service Benchmarking
- 10.9.3 Recent Developments
- 10.10 Caidya
- 10.10.1 Business Overview
- 10.10.2 Service Benchmarking
- 10.10.3 Recent Developments
List of Tables
- Table 1 Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 2 Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 3 Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 4 Clinical Operations and Development Market Assessment, By Geography, 2021 - 2034 (USD Billion)
- Table 5 North America Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
- Table 6 North America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 7 North America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 8 North America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 9 US Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 10 US Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 11 US Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 12 Canada Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 13 Canada Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 14 Canada Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 15 Europe Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
- Table 16 Europe Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 17 Europe Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 18 Europe Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 19 UK Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 20 UK Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 21 UK Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 22 France Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 23 France Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 24 France Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 25 Germany Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 26 Germany Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 27 Germany Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 28 Italy Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 29 Italy Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 30 Italy Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 31 Spain Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 32 Spain Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 33 Spain Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 34 Netherlands Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 35 Netherlands Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 36 Netherlands Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 37 Russia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 38 Russia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 39 Russia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 40 Rest of Europe Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 41 Rest of Europe Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 42 Rest of Europe Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 43 Asia Pacific Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
- Table 44 Asia Pacific Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 45 Asia Pacific Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 46 Asia Pacific Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 47 China Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 48 China Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 49 China Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 50 Japan Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 51 Japan Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 52 Japan Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 53 South Korea Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 54 South Korea Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 55 South Korea Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 56 India Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 57 India Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 58 India Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 59 Australia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 60 Australia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 61 Australia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 62 Rest of Asia Pacific Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 63 Rest of Asia Pacific Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 64 Rest of Asia Pacific Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 65 Latin America Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
- Table 66 Latin America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 67 Latin America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 68 Latin America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 69 Brazil Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 70 Brazil Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 71 Brazil Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 72 Mexico Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 73 Mexico Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 74 Mexico Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 75 Argentina Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 76 Argentina Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 77 Argentina Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 78 Rest of Latin America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 79 Rest of Latin America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 80 Rest of Latin America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 81 Middle East and Africa Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
- Table 82 Middle East and Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 83 Middle East and Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 84 Middle East and Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 85 UAE Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 86 UAE Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 87 UAE Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 88 Israel Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 89 Israel Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 90 Israel Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 91 Saudi Arabia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 92 Saudi Arabia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 93 Saudi Arabia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 94 South Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 95 South Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 96 South Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
- Table 97 Rest of Middle East & Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
- Table 98 Rest of Middle East & Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
- Table 99 Rest of Middle East & Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
List of Figures
- Figure 1. Information Procurement
- Figure 2. Primary Research Pattern
- Figure 3. Primary research process
- Figure 4. Market research approaches - Bottom-Up Approach
- Figure 5. Market research approaches - Top-Down Approach
- Figure 6. Market research approaches - Combined Approach
- Figure 7. Executive Summary
- Figure 8. Market by Region, 2024 (USD Billion)
- Figure 9. Clinical Operations and Development Market, 2021 - 2034 (USD Billion)
- Figure 10. Value Chain Analysis
- Figure 11. Porter's Five Forces
- Figure 12. PESTLE Analysis
- Figure 13. Market, By Phase
- Figure 14. Clinical Operations and Development Market, By Phase, 2024 & 2034 (USD Billion)
- Figure 15. Clinical Operations and Development Market, By Phase I, 2021 - 2034 (USD Billion)
- Figure 16. Clinical Operations and Development Market, By Phase II, 2021 - 2034 (USD Billion)
- Figure 17. Clinical Operations and Development Market, By Phase III, 2021 - 2034 (USD Billion)
- Figure 18. Clinical Operations and Development Market, By Phase IV, 2021 - 2034 (USD Billion)
- Figure 19. Market, By Service Type
- Figure 20. Clinical Operations and Development Market, By Service Type, 2024 & 2034 (USD Billion)
- Figure 21. Clinical Operations and Development Market, By Laboratory Services & Bioanalytical Testing - BA/BE, 2021 - 2034 (USD Billion)
- Figure 22. Clinical Operations and Development Market, By Data Management & Biostatistics Services, 2021 - 2034 (USD Billion)
- Figure 23. Clinical Operations and Development Market, By Site Management & Monitoring Services, 2021 - 2034 (USD Billion)
- Figure 24. Clinical Operations and Development Market, By Medical Writing & Publishing Services, 2021 - 2034 (USD Billion)
- Figure 25. Clinical Operations and Development Market, By Patient Recruitment & Retention Services, 2021 - 2034 (USD Billion)
- Figure 26. Clinical Operations and Development Market, By Others, 2021 - 2034 (USD Billion)
- Figure 27. Market, By Indication
- Figure 28. Clinical Operations and Development Market, By Indication, 2024 & 2034 (USD Billion)
- Figure 29. Clinical Operations and Development Market, By Oncology, 2021 - 2034 (USD Billion)
- Figure 30. Clinical Operations and Development Market, By Central Nervous System (CNS) Disorders, 2021 - 2034 (USD Billion)
- Figure 31. Clinical Operations and Development Market, By Cardiovascular Diseases (CVD), 2021 - 2034 (USD Billion)
- Figure 32. Clinical Operations and Development Market, By Metabolic/Endocrine, 2021 - 2034 (USD Billion)
- Figure 33. Clinical Operations and Development Market, By Respiratory, 2021 - 2034 (USD Billion)
- Figure 34. Clinical Operations and Development Market, By Infectious Diseases, 2021 - 2034 (USD Billion)
- Figure 35. Clinical Operations and Development Market, By Others, 2021 - 2034 (USD Billion)
- Figure 36. Clinical Operations and Development Market Assessment, By Geography, 2024 & 2034 (USD Billion)
